During the past decade, Athens Euroclinic conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Athens Euroclinic" #1 sponsor was "Cardiovascular Research Society, Greece" with 4 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Hellenic Cardiovascular Research Society" with 1 trials sponsored and "Hellenic Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Athens Euroclinic" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Care Across Ltd" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator and "Stavros Niarchos Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Athens Euroclinic" are "Atrial Fibrillation" (4 trials), "Coronary Artery Disease" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Angioplasty" (1 trials) and "Arterial Hypertension" (1 trials). Many other conditions were trialed in "Athens Euroclinic" in a lesser frequency.

Most popular intervention types in "Athens Euroclinic" are "Drug" (6 trials), "Other" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (2 trials), "Insulin Degludec" (2 trials), "Tirzepatide" (2 trials), "Aprocitentan 12.5 mg" (1 trials) and "Aprocitentan 25 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Athens Euroclinic" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Athens Euroclinic". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Athens Euroclinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Athens Euroclinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".